IDH1 and central nervous system cancer: The results indicated that IDH-wildtype lesions typically exhibited higher APTw intensities compared to IDH-mutant lesions, which is consistent with laboratory research showing downregulation of protein expression in mutant IDH1-driven glioma cells.